BHI News Section Archives - Page 83 of 1201

News

August 7, 2023

BioHealth Capital Region Achieves Top 3 Ranking: A Triumph of Collaboration and Innovation

In 2016, during the Annual BioHealth Capital Region Forum at MedImmune/AstraZeneca in Gaithersburg, Maryland, an ambitious goal was set: to…

Andy

Love0

News

August 7, 2023

Record Growth in Research Funding and Startups: Highlights from the 2022 AUTM Licensing Survey

The Association of University Technology Managers (AUTM) has released its annual Licensing Survey for 2022, revealing promising trends in technology…

Andy

Love0

News

August 1, 2023

MaxCyte Signs Strategic Platform License with Prime Medicine to Advance Next-Generation Gene Editing Therapies for Patients

Prime Medicine to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to advance their innovative Prime Editing technology and develop…

Andy

Love0

News

July 31, 2023

Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola

GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical…

Andy

Love0

News

July 28, 2023

Charlottesville’s RIVANNA receives $30.5 million from BARDA to advance the Accuro XV musculoskeletal imaging system

CHARLOTTESVILLE, VA, JULY 26, 2023 — RIVANNA®, developers of imaging-based medical solutions, announced that they have received funding totaling $30.5…

Andy

Love0

News

July 28, 2023

miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases

After the race to find a COVID-19 vaccine, researchers set off to explore other disease areas with similar RNA vehicles.…

Andy

Love0

News

July 27, 2023

Virginia Workforce Award to AMPEL BioSolutions

Virginia officials recognized AMPEL BioSolutions today for their dedication to identifying, training, and retaining STEM-trained workers, especially in the area…

Andy

Love0

News

July 26, 2023

Baltimore’s AsclepiX Therapeutics Raises $10 Million to Advance Clinical Study

Perceptive Advisors leads round to execute study in patients with wet age-related macular degeneration (wet AMD) BALTIMORE, MD, July 26,…

Andy

Love0

News

July 25, 2023

Virginia’s Solar Biotech Acquires VC-Backed Digital Biotech Noblegen

NORTON, Va. and PETERBOROUGH, ON, July 25, 2023 /PRNewswire/ - Solar Biotech Inc., a Norton, Virginia-based provider of complete sustainable and scalable biomanufacturing solutions, continues to…

Andy

Love0

News

July 25, 2023

United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the…

Andy

Love0

BHI News Section

BioHealth Capital Region Achieves Top 3 Ranking: A Triumph of Collaboration and Innovation

Record Growth in Research Funding and Startups: Highlights from the 2022 AUTM Licensing Survey

MaxCyte Signs Strategic Platform License with Prime Medicine to Advance Next-Generation Gene Editing Therapies for Patients

Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola

Charlottesville’s RIVANNA receives $30.5 million from BARDA to advance the Accuro XV musculoskeletal imaging system

miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases

Virginia Workforce Award to AMPEL BioSolutions

Baltimore’s AsclepiX Therapeutics Raises $10 Million to Advance Clinical Study

Virginia’s Solar Biotech Acquires VC-Backed Digital Biotech Noblegen

United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search